位置:成果数据库 > 期刊 > 期刊详情页
Liguzinediol protects against apoptosis induced by doxorubicin in H9C2cells
  • ISSN号:1000-3002
  • 期刊名称:《中国药理学与毒理学杂志》
  • 时间:0
  • 分类:R96[医药卫生—药理学;医药卫生—药学]
  • 作者机构:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica,College of Pharmacy,Nanjing University of Chinese Medicine, A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, College of Preclinical Medicine,Nanjing University of Chinese Medicine
  • 相关基金:The project supported by the National Natural Science Foundation of China(81072542);Natural Science Foundation of Jiangsu Province(BK2011077);the Research Fund for the Doctoral Program of Higher Education(20123237110010)
中文摘要:

OBJECTIVE Liguzinediol is a derivative of the natural active ingredient ligustrazine,and we found that liguzinediol has significant positive inotropic effects,which are stronger than that of TMP.Besides,it does not lead to arrhythmia,hypotension and other side effects.This study aims to investigate the anti-apoptotic effects of liguzinediolon H9C2 cells.METHODS Apoptotic H9C2 cells induced by DOX were observed by electron microscope and FCM analysis.The protein expressions of Bax,Bcl-2,caspases 3 and NF-κB were detected by Western blotting.RESULTS Apoptotic H9C2 cells induced by DOX were observed,but without apoptotic bodies in liguzinediol group.Declined peak of H9C2 cell apoptosis was seen in liguzinediol group by FCM analysis.And downregulation of Bax,caspases 3,NF-κB and upregulation of Bcl-2 were found by Western blotting.CONCLUSION Liguzinediol protected cardiomyocytes against apoptosis through downregulation of Bax and caspases 3 and upregulation of Bcl-2.Liguzinediol can inhibited cardiomyocyte apoptosis through the NF-κB signal pathway.

英文摘要:

OBJECTIVE Liguzinediol is a derivative of the natural active ingredient ligustrazine,and we found that liguzinediol has significant positive inotropic effects,which are stronger than that of TMP.Besides,it does not lead to arrhythmia,hypotension and other side effects.This study aims to investigate the anti-apoptotic effects of liguzinediolon H9C2 cells.METHODS Apoptotic H9C2 cells induced by DOX were observed by electron microscope and FCM analysis.The protein expressions of Bax,Bcl-2,caspases 3 and NF-κB were detected by Western blotting.RESULTS Apoptotic H9C2 cells induced by DOX were observed,but without apoptotic bodies in liguzinediol group.Declined peak of H9C2 cell apoptosis was seen in liguzinediol group by FCM analysis.And downregulation of Bax,caspases 3,NF-κB and upregulation of Bcl-2 were found by Western blotting.CONCLUSION Liguzinediol protected cardiomyocytes against apoptosis through downregulation of Bax and caspases 3 and upregulation of Bcl-2.Liguzinediol can inhibited cardiomyocyte apoptosis through the NF-κB signal pathway.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国药理学与毒理学杂志》
  • 北大核心期刊(2011版)
  • 主管单位:军事医学科学院
  • 主办单位:军事医学科学院毒物药物研究所 中国药理学会 中国毒理学会
  • 主编:张永祥
  • 地址:北京市海淀区太平路27号
  • 邮编:100850
  • 邮箱:cjpt518@163.com
  • 电话:010-68276743
  • 国际标准刊号:ISSN:1000-3002
  • 国内统一刊号:ISSN:11-1155/R
  • 邮发代号:82-140
  • 获奖情况:
  • 国内外数据库收录:
  • 美国化学文摘(网络版),英国农业与生物科学研究中心文摘,波兰哥白尼索引,荷兰文摘与引文数据库,荷兰医学文摘,美国剑桥科学文摘,日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:9749